The biggest cancer drug maker won U.S. Food and Drug Administration approval for Cotellic to be used in combination with the company's Zelboraf drug to treat BRAF V600 mutation-positive advanced melanoma.
Novartis said its heart failure medicine Entresto(TM) cuts 30-day hospital readmissions.
05:47 Samsung's smartphone share hit by Note7 debacle, stiff competition20
13:03 Waste Management 3rd-quarter earnings rise 11 percent11
18:37 Sumner Redstone forced to borrow $100 million from National Amusements: lawsuit13
14:35 Kim Zolciak Gets 'Cellulite Dimples' Injected With Filler — Watch The NSFW Procedure HERE!15